Document is current
Any future updates will be listed below
-
Authors
Connors, Jennifer http://orcid.org/0000-0001-9137-0717
Joyner, David
Mege, Nathan J. http://orcid.org/0000-0003-4564-7433
Cusimano, Gina M. http://orcid.org/0000-0002-1393-9485
Bell, Matthew R. http://orcid.org/0000-0001-7246-4021
Marcy, Jennifer
Taramangalam, Bhavani
Kim, Kenneth M.
Lin, Paulo J. C.
Tam, Ying K.
Weissman, Drew
Kutzler, Michele A.
Alameh, Mohamad-Gabriel
Haddad, Elias K. http://orcid.org/0000-0001-6924-4300
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (1U19 AI128910-01)
- License Information
-
More Information
Article History
Received: 2 November 2022
Accepted: 3 February 2023
First Online: 17 February 2023
Competing interests
: The authors declare the following competing interests: P.L. and Y.T. are employees of Acuitas Therapeutic. D.W. and M.G.A. are named on patents and provisional patent applications about the use of lipid nanoparticles for nucleic acid delivery. Drew Weissman is named on patents on nucleoside modifications of mRNA. The remaining authors declare no competing interests.
